SlideShare a Scribd company logo
1
3/29/2023 CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
2
RADIOPHARMACEUTICALS
•Radio activity
•Measurement of radioactivity
•Properties of α, β, γ radiations
•Half life, radio isotopes
•Study of radio isotopes - Sodium iodide I131,
•Storage conditions, precautions & pharmaceutical
application of radioactive substances
3/29/2023 CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
3
RADIOPHARMACEUTICALS
3/29/2023 CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
4
RADIOPHARMACEUTICALS
•Radiopharmaceuticals are the radioactive substances
or radioactive drugs for diagnostic or therapeutic
Use.
OR
•Radiopharmaceuticals are medicinal formulations
containing radioisotopes which are safe for
administration in humans for diagnosis or for therapy
3/29/2023 CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
5
3/29/2023 CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
6
RADIOPHARMACEUTICALS
•Radioactive
•Radioisotopes
3/29/2023 CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
7
RADIOPHARMACEUTICALS
RADIO PHARMACEUTICALS
RADIOACTIVE
3/29/2023 CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
8
RADIOPHARMACEUTICALS
•Radioactivity: The process by which certain
elements emit particular forms of radiation.
•Radioactive: Any element that emits any of
these forms of radiation.
3/29/2023 CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
9
3/29/2023 CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
10
UNITS OF RADIOACTIVITY
•Unit of Radioactivity is Curie
•Symbol as Ci or C
•It refer to activity of 1 gram of Radioactive
material and is equal to 3.7 X 1010 disintegration
per second (dps)
•1 Curie = 3.7 X 1010 dps
3/29/2023 CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
11
UNITS OF RADIOACTIVITY
•BUT nowdays unit of curie is replaced by
Rutherford(Rd).
3/29/2023 CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
12
UNITS OF RADIOACTIVITY
•The Becquerel (Bq) is the SI derived unit of
radioactivity.
• One becquerel is defined as the activity of a
quantity of radioactive material in which one
nucleus decays per second.
3/29/2023 CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
13
UNITS OF RADIOACTIVITY
•The gray (Gy) is defined as the absorbed dose of
radiation per unit mass of tissue. One gray is the
absorption of one joule of radiation energy per kilogram
of matter. The amount of radiation your cells absorb
is measured in gray.
•The Sievert (Sv) is a measure of the health effects of
low levels of ionizing radiation on the human body.
3/29/2023 CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
14
UNITS OF RADIOACTIVITY
•Roentgen: It is a unit of measurement for the exposure of X-rays and
Gamma rays.
•RAD (Radiation Absorbed Dose): It is a unit of absorbed radiation dose.
•Pharmaceutical dosage forms are described in terms of RAD units.
•RBE (Relative Biological Effectiveness): Since the effect of given radiation
on biological effectiveness depends upon the type of radiation, a unit known
as Relative Biological Effectiveness expresses the relative effects of
radiations (alpha, beta and gamma) on the biological system.
3/29/2023 CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
15
RADIOACTIVE RAYS
•All substances are made of atoms.
•These have electrons (e) around the outside, and a
nucleus in the middle.
•The nucleus consists of protons (p) and neutrons
(n), and is extremely small.
3/29/2023 CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
16
RADIOACTIVE RAYS
•In some types of atom, the nucleus is unstable, and will
decay into a more stable atom.
• This radioactive decay is completely spontaneous. -
When an unstable nucleus decays, there are three ways
that it can do so.
•It may give out:- an alpha particle (α) , beta particle (β) &
gamma ray (γ).
3/29/2023 CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
17
3/29/2023 CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
3/29/2023 18
ALPHA Particles:
1 The alpha particles are the heaviest as they are
produced when the heaviest element decay.
2.They are not waves but high energy particles which
are from unstable nuclei.
3.These are similar to Helium atom and contain two
protons and two neutrons
4.These particles are large and heavy in nature, so
cannot penetrate but easily get absorbed.
CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
3/29/2023 19
ALPHA Particles:
5.Due to less penetration of alpha particles, elements
which emit them do not find any use in biological
application as they cannot penetrate tissues.
6.They get deflected in electric and magnetic field.
7.They produce fluorescence
8.They ionize the gas through which they pass and can
penetrate through matter
CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
3/29/2023 20
BETA Particles:
1.They are much lighter energy particles and have less
ionizing power than alpha particles.
2.Beta particles are 8000 times smaller than the alpha
particles.
3.The emission of beta particles from element does not
alter the atomic mass and is converted to element with
next higher atomic number
4.Beta particles have negligible masses
CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
3/29/2023 21
BETA Particles:
5.They get deflected in electric and magnetic
field.
6.They ionize the gas through which they pass
and can penetrate through matter. Their
penetrating power is 100 times more than that
of α-particles
7.They produce fluorescence
CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
3/29/2023 22
GAMMA Particles:
1. They are having completely different character. They do not
have any charge or mass on them. It travels with the same
velocity of light.
2. Gamma rays are like X-rays, have shorter wavelength than
the visible light.
3. Penetrating power of gamma rays was found to be more
than alpha and beta rays.
4. When gamma rays are emitted from a radioactive element, no
change or loss of atomic mass or number takes place, only
there is lowering of nuclear energy.
CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
3/29/2023 23
GAMMA Particles:
5. They produce fluorescence in some materials.
6. They produce heat on the surface on which
they fall.
7. They can produce nuclear reaction.
CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
24
RADIOACTIVE RAYS
3/29/2023 CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
25
RADIOACTIVE RAYS
3/29/2023 CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
26
RADIOACTIVE RAYS
3/29/2023 CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
27
RADIOACTIVE DECAY LAW
When a radioactive material undergoes
α, β or γ-decay, the number of nuclei
undergoing the decay, per unit time, is
proportional to the total number of
nuclei in the sample material
3/29/2023 CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
28
ISOTOPES
3/29/2023 CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
29
ISOTOPES
Isotopes are atoms with the same
atomic number but different mass
numbers .
3/29/2023 CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
30
RADIOISOTOPES
Radioactive nuclide, radioisotope, radionuclide
Species of the same chemical element with
different masses whose nuclei are unstable
and dispel excess energy by spontaneously
emitting radiation in the form
of alpha, beta, and gamma rays.
3/29/2023 CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
31
RADIOISOTOPES
3/29/2023 CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
32
RADIOISOTOPES
•Most of the isotopes which occur naturally are stable.
•A few naturally occurring isotopes and all of the man-
made isotopes are unstable.
•Unstable isotopes can become stable by releasing
different types of particles.
•This process is called radioactive decay and the
elements which undergo this process are called
radioactive isotopes/radioisotopes/radionuclides.
3/29/2023 CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
33
RADIOISOTOPES
Characteristics of an isotope:
Should release high energy photon.
Should decay without particle emission.
Should be readily available.
Should have specific activity.
Should have compound ability.
3/29/2023 CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
34
APPLICATION OF
RADIOISOTOPES
a) SCIENTIFIC RESEARCH
b) ANALYTICAL
c) DIAGNOSTIC
d) THERAPEUTIC
3/29/2023 CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
35
HALF-LIFE
3/29/2023 CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
36
Certain precautions must be taken:
3/29/2023
(i)Radioactive material should never be touched with
hands but handled by means of forceps.
(ii)Food contaminated with radioactive material can
cause serious damage to internal organs, so avoid any
food intake, drinking and smoking within the lab.
(iii)Sufficient protective clothing or shielding must be
used while handling the material.
.
CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
37
Certain precautions must be taken:
3/29/2023
(iv)Radioactive material should be kept in
labelled containers and must be shielded.
(v)Area of storage must be under proper
supervision.
(vi)Disposal of radioactive material is done with
great care.
. CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
38
Labelling
3/29/2023
Every radiopharmaceutical preparation must comply with the
labelling requirements established under Good Manufacturing
Practice
The label on the primary container should include: Document
•A statement that the product is radioactive or the international
symbol for radioactivity
• the name of the radiopharmaceutical preparation;
• where appropriate, that the preparation is for diagnostic or for
therapeutic use;
• the route of administration;
• CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
39
Labelling
3/29/2023
• the total radioactivity present at a stated date and, where
necessary, time; for solutions, a statement of the
radioactivity in a suitable volume may be given instead;
• the expiry date and, where necessary, time;
• the batch (lot) number assigned by the manufacturer;
• for solutions, the total volume.
CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
40
SODIUM IODIDE (I131)
3/29/2023
Synonym: Radioactive iodine
Out of all radioactive isotopes of Iodine, I131 is most commonly used.
It is used as an aqueous solution of sodium iodide having sodium thiosulphate
in addition as a reducing agent
Method of Preparation:
Most I-131 is prepared in nuclear reactor
Standards: It should not contain less than 90% and not more than 110% of
labelled amount of Iodine-131 as iodide at the time indicating in the labelling.
CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
41
SODIUM IODIDE (I131)
3/29/2023
Properties:
It forms a colorless solution.
I131 have half-life of 8.4 days and emits beta and gamma
radiations.
Its solution is having pH range of 7 to 10.
Hyperthyroidism Treatment by I131:
Iodide inhibits the release of thyroid hormone and forms the basis for
its use in hyperthyroidism. All the isotopes of iodine are rapidly taken up by
thyroid follicles. Radioactive iodine i.e. I131 is available as Na I131 solution and
is administered orally.
CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
42
SODIUM IODIDE (I131)
3/29/2023
Uses:
•Radioactive iodine is mainly used for the diagnosis
of disorders of thyroid function.
•It is also used in the treatment of hyperthyroidism.
•Radioactive iodine is also used in the treatment of
Grave’s disease
•It is also used in radiotherapy of thyroid cancer.
CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
43
SODIUM IODIDE (I131)
3/29/2023
Packaging and Storage Condition:
The solution has to be prepared in single dose or multiple dose
containers that have been previously treated to prevent absorption.
So as to avoid absorption of radionuclides on the wall of the
container including laboratory vessels, it has been recommended that
containers used to handle sodium iodide
I-131 solution, should be first of all rinsed with a solution having
approximately 0.8% of sodium bisulphate and 0.25% of sodium iodide and
then water until the last rinsing has been neutral to litmus.
CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
44
APPLICATION OF
RADIOISOTOPES
a) SCIENTIFIC RESEARCH
b) ANALYTICAL
c) DIAGNOSTIC
d) THERAPEUTIC
3/29/2023 CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
3/29/2023 45
(i) Radioisotopes in Diagnosis:
1. Chromium in the form of sodium chromate attaches strongly to the
hemoglobin of red blood cells. This makes radioactive chromium-
151 an excellent isotope for determining the flow of blood through
the heart.
2. Ferric citrate (59Fe) injection finds the use in hematological
disorders.
3. Colloidal gold (198Au ) has been used in studying the blood
circulation in Liver.
4. Sodium iodide (131I) injection is used to study the functioning of
Thyroid gland.
CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
3/29/2023 46
(ii) Radioisotopes in Therapy
Iodine-131 is used to treat the thyroid for cancers and abnormal
conditions such as hyperthyroidism.
Phosphorus-32 is used to control the excess of RBC production in
bone marrow .
Boron-10 is used in the treatment of tumor. Boron-10 gets
concentrated in tumor and on irradiation with neutrons, it
produces high energy α-particle which kills the cancer.
Lead-212 can be attached to monoclonal antibodies for cancer
treatment.
CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
3/29/2023 47
(iii) In Research:
Excellent biological and medicinal study can be carried out
with radioactive isotopes as tracers. Generally Carbon-14 are most
commonly used.
(iv) Sterilization:
Thermolabile substances like vitamins, hormones, antibiotics
can be safely sterilized by strong radiation sources. e.g. Cobalt-60
may be used for sterilizing surgical instrument.
CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
3/29/2023 48
Sr. No. Radio-isotope Applications/Uses
1. Calcium-44, 45 (Ca-44,45) Study of bone structure and bone cancer
2. Carbon-14(C-14) Emit β-radiations, used in medical and
pharmaceutical research
3. Strontium-90(Sr-90) Pure β-emitter, used in radiotherapy of superficial
carcinoma.
4. Cobalt-60(Co-60) γ-emitter, radiotherapy , sterilization of heat labile
substances, study of vitamin B12
5. Cobalt-57(Co-57) Used in diagnosis of pernicious anemia
CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
49
Measurement of Radioactivity
3/29/2023
•The measurement of nuclear radiation and detection is
an important aspect in the identification of type of
radiations (, , ) and to assay the radionuclide emitting
the radiation, suitable detectors are required.
•The radiations are identified on the basis of their
properties.
CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
50
CLASSIFICATION
3/29/2023
A)Based on measuring discharge current due to ionization
current
e.g. Geiger–Müller counter, proportional counter
B) Based on visualization of track of ions
e.g. bubble chamber, Cloud chamber
C) Based on Light emission
e.g. Scintillation counter
CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
51
OTHER …..
3/29/2023
Semiconductor Detector:
Solid State Detectors:
CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D

More Related Content

What's hot

SOURCES OF ERROR IN PRESCRIPTION
SOURCES OF ERROR IN PRESCRIPTIONSOURCES OF ERROR IN PRESCRIPTION
SOURCES OF ERROR IN PRESCRIPTION
Nithya Murugan
 
CHAPTER DENTAL PRODUCTS .pptx
CHAPTER DENTAL PRODUCTS .pptxCHAPTER DENTAL PRODUCTS .pptx
CHAPTER DENTAL PRODUCTS .pptx
Sayali Powar
 
Classical dosage forms-by Amna Saeed
Classical dosage forms-by Amna SaeedClassical dosage forms-by Amna Saeed
Classical dosage forms-by Amna Saeed
Amna Saeed
 
Antidiabetic agents.pptx
Antidiabetic agents.pptxAntidiabetic agents.pptx
Antidiabetic agents.pptx
SDSHANMUGAKUMAR
 
SALINE CATAHRTICS
SALINE CATAHRTICSSALINE CATAHRTICS
SALINE CATAHRTICS
TAUFIK MULLA
 
Powder dosage forms
Powder dosage formsPowder dosage forms
Powder dosage forms
Parag Jain
 
Dental products.pptx
Dental products.pptxDental products.pptx
Dental products.pptx
Ms. Pooja Bhandare
 
suppostories by A B Walikar
suppostories by A B Walikarsuppostories by A B Walikar
suppostories by A B Walikar
walikararun
 
Calcium channel blockers (cc bs)
Calcium channel blockers (cc bs)Calcium channel blockers (cc bs)
Calcium channel blockers (cc bs)
Kalam Sirisha
 
Powders
PowdersPowders
Practical notes for Pharmacy (Synopsis and viva questions included) reference...
Practical notes for Pharmacy (Synopsis and viva questions included) reference...Practical notes for Pharmacy (Synopsis and viva questions included) reference...
Practical notes for Pharmacy (Synopsis and viva questions included) reference...
Payaamvohra1
 
Pharmaceutical dosage form BY ABARAJITHA&MUTHUKUMAR KMCH COP
Pharmaceutical dosage form BY ABARAJITHA&MUTHUKUMAR KMCH COPPharmaceutical dosage form BY ABARAJITHA&MUTHUKUMAR KMCH COP
Pharmaceutical dosage form BY ABARAJITHA&MUTHUKUMAR KMCH COP
KMCH COLLEGE OF PHARMACY
 
Paediatrics
PaediatricsPaediatrics
Paediatrics
Virendra Neve
 
Tablet
TabletTablet
local anesthetics / Medicinal Chemistry
local anesthetics / Medicinal Chemistry local anesthetics / Medicinal Chemistry
local anesthetics / Medicinal Chemistry
NarminHamaaminHussen
 
Major extra and intracellular electrolytes. Pharmaceutical Inorganic chemistr...
Major extra and intracellular electrolytes. Pharmaceutical Inorganic chemistr...Major extra and intracellular electrolytes. Pharmaceutical Inorganic chemistr...
Major extra and intracellular electrolytes. Pharmaceutical Inorganic chemistr...
Ms. Pooja Bhandare
 

What's hot (20)

SOURCES OF ERROR IN PRESCRIPTION
SOURCES OF ERROR IN PRESCRIPTIONSOURCES OF ERROR IN PRESCRIPTION
SOURCES OF ERROR IN PRESCRIPTION
 
CHAPTER DENTAL PRODUCTS .pptx
CHAPTER DENTAL PRODUCTS .pptxCHAPTER DENTAL PRODUCTS .pptx
CHAPTER DENTAL PRODUCTS .pptx
 
ROUTE OF ADMINISTRATION
ROUTE OF ADMINISTRATIONROUTE OF ADMINISTRATION
ROUTE OF ADMINISTRATION
 
Classical dosage forms-by Amna Saeed
Classical dosage forms-by Amna SaeedClassical dosage forms-by Amna Saeed
Classical dosage forms-by Amna Saeed
 
Antidiabetic agents.pptx
Antidiabetic agents.pptxAntidiabetic agents.pptx
Antidiabetic agents.pptx
 
Rectal dds
Rectal ddsRectal dds
Rectal dds
 
SALINE CATAHRTICS
SALINE CATAHRTICSSALINE CATAHRTICS
SALINE CATAHRTICS
 
Chapter 4 Pharmacology
Chapter 4   PharmacologyChapter 4   Pharmacology
Chapter 4 Pharmacology
 
Powder dosage forms
Powder dosage formsPowder dosage forms
Powder dosage forms
 
Dental products.pptx
Dental products.pptxDental products.pptx
Dental products.pptx
 
suppostories by A B Walikar
suppostories by A B Walikarsuppostories by A B Walikar
suppostories by A B Walikar
 
Calcium channel blockers (cc bs)
Calcium channel blockers (cc bs)Calcium channel blockers (cc bs)
Calcium channel blockers (cc bs)
 
Powders
PowdersPowders
Powders
 
Practical notes for Pharmacy (Synopsis and viva questions included) reference...
Practical notes for Pharmacy (Synopsis and viva questions included) reference...Practical notes for Pharmacy (Synopsis and viva questions included) reference...
Practical notes for Pharmacy (Synopsis and viva questions included) reference...
 
Pharmaceutical dosage form BY ABARAJITHA&MUTHUKUMAR KMCH COP
Pharmaceutical dosage form BY ABARAJITHA&MUTHUKUMAR KMCH COPPharmaceutical dosage form BY ABARAJITHA&MUTHUKUMAR KMCH COP
Pharmaceutical dosage form BY ABARAJITHA&MUTHUKUMAR KMCH COP
 
Paediatrics
PaediatricsPaediatrics
Paediatrics
 
Tablet
TabletTablet
Tablet
 
ODT project protocol-Reshma
ODT project protocol-ReshmaODT project protocol-Reshma
ODT project protocol-Reshma
 
local anesthetics / Medicinal Chemistry
local anesthetics / Medicinal Chemistry local anesthetics / Medicinal Chemistry
local anesthetics / Medicinal Chemistry
 
Major extra and intracellular electrolytes. Pharmaceutical Inorganic chemistr...
Major extra and intracellular electrolytes. Pharmaceutical Inorganic chemistr...Major extra and intracellular electrolytes. Pharmaceutical Inorganic chemistr...
Major extra and intracellular electrolytes. Pharmaceutical Inorganic chemistr...
 

Similar to CHAPTER 21.pptx

Unit 5
Unit 5 Unit 5
Unit 5
Sayali Powar
 
UNIT 5.pptx
UNIT 5.pptxUNIT 5.pptx
UNIT 5.pptx
Sayali Powar
 
Applications of radiopharmaceuticals
Applications of radiopharmaceuticalsApplications of radiopharmaceuticals
Applications of radiopharmaceuticals
jagan vana
 
Radiopharmaceuticals: Pharmacy academics.pptx
Radiopharmaceuticals: Pharmacy academics.pptxRadiopharmaceuticals: Pharmacy academics.pptx
Radiopharmaceuticals: Pharmacy academics.pptx
nsppharmacist
 
Radiopharmaceuticals and contrast media.
Radiopharmaceuticals and contrast media.Radiopharmaceuticals and contrast media.
Radiopharmaceuticals and contrast media.
amruta kadam
 
Radiochemistry & Radiopharmaceuticals.
Radiochemistry & Radiopharmaceuticals. Radiochemistry & Radiopharmaceuticals.
Radiochemistry & Radiopharmaceuticals.
Rohan Jagdale
 
Radiopharmaceu.pdf
Radiopharmaceu.pdfRadiopharmaceu.pdf
Radiopharmaceu.pdf
SonuYadav322737
 
Illustrative Review on Radiopharmaceuticals
Illustrative Review on RadiopharmaceuticalsIllustrative Review on Radiopharmaceuticals
Illustrative Review on Radiopharmaceuticals
ijtsrd
 
RADIOPHARMACEUTICAL.pptx
RADIOPHARMACEUTICAL.pptxRADIOPHARMACEUTICAL.pptx
RADIOPHARMACEUTICAL.pptx
Archana Chavhan
 
Radioactivity
RadioactivityRadioactivity
Radioactivity
Damion Lawrence
 
Radiation protection
Radiation protectionRadiation protection
Radiation protection
Meera Avadhani
 
Radiopharmaceutical presentation
Radiopharmaceutical presentationRadiopharmaceutical presentation
Radiopharmaceutical presentation
laraib jameel
 
Radiopharmaceuticals
RadiopharmaceuticalsRadiopharmaceuticals
Radiopharmaceuticals
Dr Yogi Pandya
 
Radiation safety training_manual
Radiation safety training_manualRadiation safety training_manual
Radiation safety training_manual
Huy Tran Quang
 
Radiopharmaceuticals.ppt
Radiopharmaceuticals.pptRadiopharmaceuticals.ppt
Radiopharmaceuticals.ppt
KunalDatta13
 
Nuclear Medicine.pdf
Nuclear Medicine.pdfNuclear Medicine.pdf
Nuclear Medicine.pdf
ASPhoenix
 
Radiopharmaceuticals
RadiopharmaceuticalsRadiopharmaceuticals
Radiopharmaceuticals
ESHA SHAH
 
Guide for Using Lead as Radiation Shielding
Guide for Using Lead as Radiation ShieldingGuide for Using Lead as Radiation Shielding
Guide for Using Lead as Radiation Shielding
canadametal
 
RADIATION PROTECTION OFFICER study material
RADIATION PROTECTION OFFICER study materialRADIATION PROTECTION OFFICER study material
RADIATION PROTECTION OFFICER study material
Assad Saghir
 

Similar to CHAPTER 21.pptx (20)

Unit 5
Unit 5 Unit 5
Unit 5
 
UNIT 5.pptx
UNIT 5.pptxUNIT 5.pptx
UNIT 5.pptx
 
Applications of radiopharmaceuticals
Applications of radiopharmaceuticalsApplications of radiopharmaceuticals
Applications of radiopharmaceuticals
 
Radiopharmaceuticals: Pharmacy academics.pptx
Radiopharmaceuticals: Pharmacy academics.pptxRadiopharmaceuticals: Pharmacy academics.pptx
Radiopharmaceuticals: Pharmacy academics.pptx
 
Radiopharmaceuticals and contrast media.
Radiopharmaceuticals and contrast media.Radiopharmaceuticals and contrast media.
Radiopharmaceuticals and contrast media.
 
Radiochemistry & Radiopharmaceuticals.
Radiochemistry & Radiopharmaceuticals. Radiochemistry & Radiopharmaceuticals.
Radiochemistry & Radiopharmaceuticals.
 
Radiopharmaceu.pdf
Radiopharmaceu.pdfRadiopharmaceu.pdf
Radiopharmaceu.pdf
 
Illustrative Review on Radiopharmaceuticals
Illustrative Review on RadiopharmaceuticalsIllustrative Review on Radiopharmaceuticals
Illustrative Review on Radiopharmaceuticals
 
RADIOPHARMACEUTICAL.pptx
RADIOPHARMACEUTICAL.pptxRADIOPHARMACEUTICAL.pptx
RADIOPHARMACEUTICAL.pptx
 
Radioactivity
RadioactivityRadioactivity
Radioactivity
 
Radiation protection
Radiation protectionRadiation protection
Radiation protection
 
Radiopharmaceutical presentation
Radiopharmaceutical presentationRadiopharmaceutical presentation
Radiopharmaceutical presentation
 
Radiopharmaceuticals
RadiopharmaceuticalsRadiopharmaceuticals
Radiopharmaceuticals
 
Radiation safety training_manual
Radiation safety training_manualRadiation safety training_manual
Radiation safety training_manual
 
Radiopharmaceuticals.ppt
Radiopharmaceuticals.pptRadiopharmaceuticals.ppt
Radiopharmaceuticals.ppt
 
Nuclear Medicine.pdf
Nuclear Medicine.pdfNuclear Medicine.pdf
Nuclear Medicine.pdf
 
Radioactivity
RadioactivityRadioactivity
Radioactivity
 
Radiopharmaceuticals
RadiopharmaceuticalsRadiopharmaceuticals
Radiopharmaceuticals
 
Guide for Using Lead as Radiation Shielding
Guide for Using Lead as Radiation ShieldingGuide for Using Lead as Radiation Shielding
Guide for Using Lead as Radiation Shielding
 
RADIATION PROTECTION OFFICER study material
RADIATION PROTECTION OFFICER study materialRADIATION PROTECTION OFFICER study material
RADIATION PROTECTION OFFICER study material
 

More from Sayali Powar

UNIT 1_QUALITY ASSURANCE_QC,QA,GMP,TQM and NABL
UNIT 1_QUALITY ASSURANCE_QC,QA,GMP,TQM and NABLUNIT 1_QUALITY ASSURANCE_QC,QA,GMP,TQM and NABL
UNIT 1_QUALITY ASSURANCE_QC,QA,GMP,TQM and NABL
Sayali Powar
 
UNIT – IV_PCI Complaints: Complaints and evaluation of complaints, Handling o...
UNIT – IV_PCI Complaints: Complaints and evaluation of complaints, Handling o...UNIT – IV_PCI Complaints: Complaints and evaluation of complaints, Handling o...
UNIT – IV_PCI Complaints: Complaints and evaluation of complaints, Handling o...
Sayali Powar
 
UNIT 1 QUALITY ASSURANCE B. PHARMACY PART 2
UNIT 1 QUALITY ASSURANCE B. PHARMACY PART 2UNIT 1 QUALITY ASSURANCE B. PHARMACY PART 2
UNIT 1 QUALITY ASSURANCE B. PHARMACY PART 2
Sayali Powar
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
Sayali Powar
 
BIOCHEMISTRY-CARBOHYDRATE METABOLISM CHAPTER 2.pptx
BIOCHEMISTRY-CARBOHYDRATE METABOLISM CHAPTER 2.pptxBIOCHEMISTRY-CARBOHYDRATE METABOLISM CHAPTER 2.pptx
BIOCHEMISTRY-CARBOHYDRATE METABOLISM CHAPTER 2.pptx
Sayali Powar
 
Quality Assurance_GOOD LABORATORY PRACTICE
Quality Assurance_GOOD LABORATORY PRACTICEQuality Assurance_GOOD LABORATORY PRACTICE
Quality Assurance_GOOD LABORATORY PRACTICE
Sayali Powar
 
PPT ON ORGANIZATION,PERSONNEL, PREMISES.pptx
PPT ON ORGANIZATION,PERSONNEL, PREMISES.pptxPPT ON ORGANIZATION,PERSONNEL, PREMISES.pptx
PPT ON ORGANIZATION,PERSONNEL, PREMISES.pptx
Sayali Powar
 
QC test for Packaging Materials used in Pharmaceuticals.pptx
QC test for Packaging Materials used in Pharmaceuticals.pptxQC test for Packaging Materials used in Pharmaceuticals.pptx
QC test for Packaging Materials used in Pharmaceuticals.pptx
Sayali Powar
 
Types of Packaging Materials used in Pharmaceuticals.pptx
Types of Packaging Materials used in Pharmaceuticals.pptxTypes of Packaging Materials used in Pharmaceuticals.pptx
Types of Packaging Materials used in Pharmaceuticals.pptx
Sayali Powar
 
UNIT 1 BIOCHEMISTRY_BIOMOLECULE_MINI PROJECT.pdf
UNIT 1 BIOCHEMISTRY_BIOMOLECULE_MINI PROJECT.pdfUNIT 1 BIOCHEMISTRY_BIOMOLECULE_MINI PROJECT.pdf
UNIT 1 BIOCHEMISTRY_BIOMOLECULE_MINI PROJECT.pdf
Sayali Powar
 
Biochemistry_Unit 1_Bioenergetics notes
Biochemistry_Unit  1_Bioenergetics notesBiochemistry_Unit  1_Bioenergetics notes
Biochemistry_Unit 1_Bioenergetics notes
Sayali Powar
 
PROTEIN,AMINO ACID AND NULEIC ACID_UNIT 1
PROTEIN,AMINO ACID AND NULEIC ACID_UNIT 1PROTEIN,AMINO ACID AND NULEIC ACID_UNIT 1
PROTEIN,AMINO ACID AND NULEIC ACID_UNIT 1
Sayali Powar
 
LIPIDS UNIT ONE BIOMOLECULE PRESENTATION
LIPIDS UNIT ONE BIOMOLECULE PRESENTATIONLIPIDS UNIT ONE BIOMOLECULE PRESENTATION
LIPIDS UNIT ONE BIOMOLECULE PRESENTATION
Sayali Powar
 
UNIT 1 BIOMOLECULE_CARBOHYDRATES PRESENTATION
UNIT 1 BIOMOLECULE_CARBOHYDRATES PRESENTATIONUNIT 1 BIOMOLECULE_CARBOHYDRATES PRESENTATION
UNIT 1 BIOMOLECULE_CARBOHYDRATES PRESENTATION
Sayali Powar
 
UNIT 3 QUALITY ASSURANCE LECTURE 3.pptx
UNIT 3 QUALITY ASSURANCE  LECTURE 3.pptxUNIT 3 QUALITY ASSURANCE  LECTURE 3.pptx
UNIT 3 QUALITY ASSURANCE LECTURE 3.pptx
Sayali Powar
 
PHARMACEUTICAL QUALITY ASSURANCE _UNIT 3 Quality Control
PHARMACEUTICAL QUALITY ASSURANCE _UNIT 3 Quality ControlPHARMACEUTICAL QUALITY ASSURANCE _UNIT 3 Quality Control
PHARMACEUTICAL QUALITY ASSURANCE _UNIT 3 Quality Control
Sayali Powar
 
CHAPTER 8.pptx
CHAPTER 8.pptxCHAPTER 8.pptx
CHAPTER 8.pptx
Sayali Powar
 
unit 4.pptx
unit 4.pptxunit 4.pptx
unit 4.pptx
Sayali Powar
 
unit 5.pptx
unit 5.pptxunit 5.pptx
unit 5.pptx
Sayali Powar
 
IRON DEFIENCY ANEMIA.pptx
IRON DEFIENCY ANEMIA.pptxIRON DEFIENCY ANEMIA.pptx
IRON DEFIENCY ANEMIA.pptx
Sayali Powar
 

More from Sayali Powar (20)

UNIT 1_QUALITY ASSURANCE_QC,QA,GMP,TQM and NABL
UNIT 1_QUALITY ASSURANCE_QC,QA,GMP,TQM and NABLUNIT 1_QUALITY ASSURANCE_QC,QA,GMP,TQM and NABL
UNIT 1_QUALITY ASSURANCE_QC,QA,GMP,TQM and NABL
 
UNIT – IV_PCI Complaints: Complaints and evaluation of complaints, Handling o...
UNIT – IV_PCI Complaints: Complaints and evaluation of complaints, Handling o...UNIT – IV_PCI Complaints: Complaints and evaluation of complaints, Handling o...
UNIT – IV_PCI Complaints: Complaints and evaluation of complaints, Handling o...
 
UNIT 1 QUALITY ASSURANCE B. PHARMACY PART 2
UNIT 1 QUALITY ASSURANCE B. PHARMACY PART 2UNIT 1 QUALITY ASSURANCE B. PHARMACY PART 2
UNIT 1 QUALITY ASSURANCE B. PHARMACY PART 2
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
 
BIOCHEMISTRY-CARBOHYDRATE METABOLISM CHAPTER 2.pptx
BIOCHEMISTRY-CARBOHYDRATE METABOLISM CHAPTER 2.pptxBIOCHEMISTRY-CARBOHYDRATE METABOLISM CHAPTER 2.pptx
BIOCHEMISTRY-CARBOHYDRATE METABOLISM CHAPTER 2.pptx
 
Quality Assurance_GOOD LABORATORY PRACTICE
Quality Assurance_GOOD LABORATORY PRACTICEQuality Assurance_GOOD LABORATORY PRACTICE
Quality Assurance_GOOD LABORATORY PRACTICE
 
PPT ON ORGANIZATION,PERSONNEL, PREMISES.pptx
PPT ON ORGANIZATION,PERSONNEL, PREMISES.pptxPPT ON ORGANIZATION,PERSONNEL, PREMISES.pptx
PPT ON ORGANIZATION,PERSONNEL, PREMISES.pptx
 
QC test for Packaging Materials used in Pharmaceuticals.pptx
QC test for Packaging Materials used in Pharmaceuticals.pptxQC test for Packaging Materials used in Pharmaceuticals.pptx
QC test for Packaging Materials used in Pharmaceuticals.pptx
 
Types of Packaging Materials used in Pharmaceuticals.pptx
Types of Packaging Materials used in Pharmaceuticals.pptxTypes of Packaging Materials used in Pharmaceuticals.pptx
Types of Packaging Materials used in Pharmaceuticals.pptx
 
UNIT 1 BIOCHEMISTRY_BIOMOLECULE_MINI PROJECT.pdf
UNIT 1 BIOCHEMISTRY_BIOMOLECULE_MINI PROJECT.pdfUNIT 1 BIOCHEMISTRY_BIOMOLECULE_MINI PROJECT.pdf
UNIT 1 BIOCHEMISTRY_BIOMOLECULE_MINI PROJECT.pdf
 
Biochemistry_Unit 1_Bioenergetics notes
Biochemistry_Unit  1_Bioenergetics notesBiochemistry_Unit  1_Bioenergetics notes
Biochemistry_Unit 1_Bioenergetics notes
 
PROTEIN,AMINO ACID AND NULEIC ACID_UNIT 1
PROTEIN,AMINO ACID AND NULEIC ACID_UNIT 1PROTEIN,AMINO ACID AND NULEIC ACID_UNIT 1
PROTEIN,AMINO ACID AND NULEIC ACID_UNIT 1
 
LIPIDS UNIT ONE BIOMOLECULE PRESENTATION
LIPIDS UNIT ONE BIOMOLECULE PRESENTATIONLIPIDS UNIT ONE BIOMOLECULE PRESENTATION
LIPIDS UNIT ONE BIOMOLECULE PRESENTATION
 
UNIT 1 BIOMOLECULE_CARBOHYDRATES PRESENTATION
UNIT 1 BIOMOLECULE_CARBOHYDRATES PRESENTATIONUNIT 1 BIOMOLECULE_CARBOHYDRATES PRESENTATION
UNIT 1 BIOMOLECULE_CARBOHYDRATES PRESENTATION
 
UNIT 3 QUALITY ASSURANCE LECTURE 3.pptx
UNIT 3 QUALITY ASSURANCE  LECTURE 3.pptxUNIT 3 QUALITY ASSURANCE  LECTURE 3.pptx
UNIT 3 QUALITY ASSURANCE LECTURE 3.pptx
 
PHARMACEUTICAL QUALITY ASSURANCE _UNIT 3 Quality Control
PHARMACEUTICAL QUALITY ASSURANCE _UNIT 3 Quality ControlPHARMACEUTICAL QUALITY ASSURANCE _UNIT 3 Quality Control
PHARMACEUTICAL QUALITY ASSURANCE _UNIT 3 Quality Control
 
CHAPTER 8.pptx
CHAPTER 8.pptxCHAPTER 8.pptx
CHAPTER 8.pptx
 
unit 4.pptx
unit 4.pptxunit 4.pptx
unit 4.pptx
 
unit 5.pptx
unit 5.pptxunit 5.pptx
unit 5.pptx
 
IRON DEFIENCY ANEMIA.pptx
IRON DEFIENCY ANEMIA.pptxIRON DEFIENCY ANEMIA.pptx
IRON DEFIENCY ANEMIA.pptx
 

Recently uploaded

Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
Jean Carlos Nunes Paixão
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
EugeneSaldivar
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
Special education needs
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
DeeptiGupta154
 
Digital Artifact 2 - Investigating Pavilion Designs
Digital Artifact 2 - Investigating Pavilion DesignsDigital Artifact 2 - Investigating Pavilion Designs
Digital Artifact 2 - Investigating Pavilion Designs
chanes7
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
Peter Windle
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
camakaiclarkmusic
 
The basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptxThe basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptx
heathfieldcps1
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
Jisc
 
S1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptxS1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptx
tarandeep35
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
SACHIN R KONDAGURI
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
Vikramjit Singh
 
Best Digital Marketing Institute In NOIDA
Best Digital Marketing Institute In NOIDABest Digital Marketing Institute In NOIDA
Best Digital Marketing Institute In NOIDA
deeptiverma2406
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
vaibhavrinwa19
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
MysoreMuleSoftMeetup
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
Delapenabediema
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
Vivekanand Anglo Vedic Academy
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
Ashokrao Mane college of Pharmacy Peth-Vadgaon
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
Jisc
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 

Recently uploaded (20)

Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
 
Digital Artifact 2 - Investigating Pavilion Designs
Digital Artifact 2 - Investigating Pavilion DesignsDigital Artifact 2 - Investigating Pavilion Designs
Digital Artifact 2 - Investigating Pavilion Designs
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
 
The basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptxThe basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptx
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
 
S1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptxS1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptx
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
 
Best Digital Marketing Institute In NOIDA
Best Digital Marketing Institute In NOIDABest Digital Marketing Institute In NOIDA
Best Digital Marketing Institute In NOIDA
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
 

CHAPTER 21.pptx

  • 1. 1 3/29/2023 CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
  • 2. 2 RADIOPHARMACEUTICALS •Radio activity •Measurement of radioactivity •Properties of α, β, γ radiations •Half life, radio isotopes •Study of radio isotopes - Sodium iodide I131, •Storage conditions, precautions & pharmaceutical application of radioactive substances 3/29/2023 CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
  • 3. 3 RADIOPHARMACEUTICALS 3/29/2023 CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
  • 4. 4 RADIOPHARMACEUTICALS •Radiopharmaceuticals are the radioactive substances or radioactive drugs for diagnostic or therapeutic Use. OR •Radiopharmaceuticals are medicinal formulations containing radioisotopes which are safe for administration in humans for diagnosis or for therapy 3/29/2023 CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
  • 5. 5 3/29/2023 CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
  • 8. 8 RADIOPHARMACEUTICALS •Radioactivity: The process by which certain elements emit particular forms of radiation. •Radioactive: Any element that emits any of these forms of radiation. 3/29/2023 CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
  • 9. 9 3/29/2023 CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
  • 10. 10 UNITS OF RADIOACTIVITY •Unit of Radioactivity is Curie •Symbol as Ci or C •It refer to activity of 1 gram of Radioactive material and is equal to 3.7 X 1010 disintegration per second (dps) •1 Curie = 3.7 X 1010 dps 3/29/2023 CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
  • 11. 11 UNITS OF RADIOACTIVITY •BUT nowdays unit of curie is replaced by Rutherford(Rd). 3/29/2023 CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
  • 12. 12 UNITS OF RADIOACTIVITY •The Becquerel (Bq) is the SI derived unit of radioactivity. • One becquerel is defined as the activity of a quantity of radioactive material in which one nucleus decays per second. 3/29/2023 CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
  • 13. 13 UNITS OF RADIOACTIVITY •The gray (Gy) is defined as the absorbed dose of radiation per unit mass of tissue. One gray is the absorption of one joule of radiation energy per kilogram of matter. The amount of radiation your cells absorb is measured in gray. •The Sievert (Sv) is a measure of the health effects of low levels of ionizing radiation on the human body. 3/29/2023 CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
  • 14. 14 UNITS OF RADIOACTIVITY •Roentgen: It is a unit of measurement for the exposure of X-rays and Gamma rays. •RAD (Radiation Absorbed Dose): It is a unit of absorbed radiation dose. •Pharmaceutical dosage forms are described in terms of RAD units. •RBE (Relative Biological Effectiveness): Since the effect of given radiation on biological effectiveness depends upon the type of radiation, a unit known as Relative Biological Effectiveness expresses the relative effects of radiations (alpha, beta and gamma) on the biological system. 3/29/2023 CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
  • 15. 15 RADIOACTIVE RAYS •All substances are made of atoms. •These have electrons (e) around the outside, and a nucleus in the middle. •The nucleus consists of protons (p) and neutrons (n), and is extremely small. 3/29/2023 CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
  • 16. 16 RADIOACTIVE RAYS •In some types of atom, the nucleus is unstable, and will decay into a more stable atom. • This radioactive decay is completely spontaneous. - When an unstable nucleus decays, there are three ways that it can do so. •It may give out:- an alpha particle (α) , beta particle (β) & gamma ray (γ). 3/29/2023 CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
  • 17. 17 3/29/2023 CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
  • 18. 3/29/2023 18 ALPHA Particles: 1 The alpha particles are the heaviest as they are produced when the heaviest element decay. 2.They are not waves but high energy particles which are from unstable nuclei. 3.These are similar to Helium atom and contain two protons and two neutrons 4.These particles are large and heavy in nature, so cannot penetrate but easily get absorbed. CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
  • 19. 3/29/2023 19 ALPHA Particles: 5.Due to less penetration of alpha particles, elements which emit them do not find any use in biological application as they cannot penetrate tissues. 6.They get deflected in electric and magnetic field. 7.They produce fluorescence 8.They ionize the gas through which they pass and can penetrate through matter CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
  • 20. 3/29/2023 20 BETA Particles: 1.They are much lighter energy particles and have less ionizing power than alpha particles. 2.Beta particles are 8000 times smaller than the alpha particles. 3.The emission of beta particles from element does not alter the atomic mass and is converted to element with next higher atomic number 4.Beta particles have negligible masses CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
  • 21. 3/29/2023 21 BETA Particles: 5.They get deflected in electric and magnetic field. 6.They ionize the gas through which they pass and can penetrate through matter. Their penetrating power is 100 times more than that of α-particles 7.They produce fluorescence CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
  • 22. 3/29/2023 22 GAMMA Particles: 1. They are having completely different character. They do not have any charge or mass on them. It travels with the same velocity of light. 2. Gamma rays are like X-rays, have shorter wavelength than the visible light. 3. Penetrating power of gamma rays was found to be more than alpha and beta rays. 4. When gamma rays are emitted from a radioactive element, no change or loss of atomic mass or number takes place, only there is lowering of nuclear energy. CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
  • 23. 3/29/2023 23 GAMMA Particles: 5. They produce fluorescence in some materials. 6. They produce heat on the surface on which they fall. 7. They can produce nuclear reaction. CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
  • 24. 24 RADIOACTIVE RAYS 3/29/2023 CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
  • 25. 25 RADIOACTIVE RAYS 3/29/2023 CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
  • 26. 26 RADIOACTIVE RAYS 3/29/2023 CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
  • 27. 27 RADIOACTIVE DECAY LAW When a radioactive material undergoes α, β or γ-decay, the number of nuclei undergoing the decay, per unit time, is proportional to the total number of nuclei in the sample material 3/29/2023 CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
  • 28. 28 ISOTOPES 3/29/2023 CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
  • 29. 29 ISOTOPES Isotopes are atoms with the same atomic number but different mass numbers . 3/29/2023 CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
  • 30. 30 RADIOISOTOPES Radioactive nuclide, radioisotope, radionuclide Species of the same chemical element with different masses whose nuclei are unstable and dispel excess energy by spontaneously emitting radiation in the form of alpha, beta, and gamma rays. 3/29/2023 CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
  • 31. 31 RADIOISOTOPES 3/29/2023 CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
  • 32. 32 RADIOISOTOPES •Most of the isotopes which occur naturally are stable. •A few naturally occurring isotopes and all of the man- made isotopes are unstable. •Unstable isotopes can become stable by releasing different types of particles. •This process is called radioactive decay and the elements which undergo this process are called radioactive isotopes/radioisotopes/radionuclides. 3/29/2023 CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
  • 33. 33 RADIOISOTOPES Characteristics of an isotope: Should release high energy photon. Should decay without particle emission. Should be readily available. Should have specific activity. Should have compound ability. 3/29/2023 CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
  • 34. 34 APPLICATION OF RADIOISOTOPES a) SCIENTIFIC RESEARCH b) ANALYTICAL c) DIAGNOSTIC d) THERAPEUTIC 3/29/2023 CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
  • 35. 35 HALF-LIFE 3/29/2023 CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
  • 36. 36 Certain precautions must be taken: 3/29/2023 (i)Radioactive material should never be touched with hands but handled by means of forceps. (ii)Food contaminated with radioactive material can cause serious damage to internal organs, so avoid any food intake, drinking and smoking within the lab. (iii)Sufficient protective clothing or shielding must be used while handling the material. . CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
  • 37. 37 Certain precautions must be taken: 3/29/2023 (iv)Radioactive material should be kept in labelled containers and must be shielded. (v)Area of storage must be under proper supervision. (vi)Disposal of radioactive material is done with great care. . CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
  • 38. 38 Labelling 3/29/2023 Every radiopharmaceutical preparation must comply with the labelling requirements established under Good Manufacturing Practice The label on the primary container should include: Document •A statement that the product is radioactive or the international symbol for radioactivity • the name of the radiopharmaceutical preparation; • where appropriate, that the preparation is for diagnostic or for therapeutic use; • the route of administration; • CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
  • 39. 39 Labelling 3/29/2023 • the total radioactivity present at a stated date and, where necessary, time; for solutions, a statement of the radioactivity in a suitable volume may be given instead; • the expiry date and, where necessary, time; • the batch (lot) number assigned by the manufacturer; • for solutions, the total volume. CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
  • 40. 40 SODIUM IODIDE (I131) 3/29/2023 Synonym: Radioactive iodine Out of all radioactive isotopes of Iodine, I131 is most commonly used. It is used as an aqueous solution of sodium iodide having sodium thiosulphate in addition as a reducing agent Method of Preparation: Most I-131 is prepared in nuclear reactor Standards: It should not contain less than 90% and not more than 110% of labelled amount of Iodine-131 as iodide at the time indicating in the labelling. CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
  • 41. 41 SODIUM IODIDE (I131) 3/29/2023 Properties: It forms a colorless solution. I131 have half-life of 8.4 days and emits beta and gamma radiations. Its solution is having pH range of 7 to 10. Hyperthyroidism Treatment by I131: Iodide inhibits the release of thyroid hormone and forms the basis for its use in hyperthyroidism. All the isotopes of iodine are rapidly taken up by thyroid follicles. Radioactive iodine i.e. I131 is available as Na I131 solution and is administered orally. CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
  • 42. 42 SODIUM IODIDE (I131) 3/29/2023 Uses: •Radioactive iodine is mainly used for the diagnosis of disorders of thyroid function. •It is also used in the treatment of hyperthyroidism. •Radioactive iodine is also used in the treatment of Grave’s disease •It is also used in radiotherapy of thyroid cancer. CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
  • 43. 43 SODIUM IODIDE (I131) 3/29/2023 Packaging and Storage Condition: The solution has to be prepared in single dose or multiple dose containers that have been previously treated to prevent absorption. So as to avoid absorption of radionuclides on the wall of the container including laboratory vessels, it has been recommended that containers used to handle sodium iodide I-131 solution, should be first of all rinsed with a solution having approximately 0.8% of sodium bisulphate and 0.25% of sodium iodide and then water until the last rinsing has been neutral to litmus. CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
  • 44. 44 APPLICATION OF RADIOISOTOPES a) SCIENTIFIC RESEARCH b) ANALYTICAL c) DIAGNOSTIC d) THERAPEUTIC 3/29/2023 CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
  • 45. 3/29/2023 45 (i) Radioisotopes in Diagnosis: 1. Chromium in the form of sodium chromate attaches strongly to the hemoglobin of red blood cells. This makes radioactive chromium- 151 an excellent isotope for determining the flow of blood through the heart. 2. Ferric citrate (59Fe) injection finds the use in hematological disorders. 3. Colloidal gold (198Au ) has been used in studying the blood circulation in Liver. 4. Sodium iodide (131I) injection is used to study the functioning of Thyroid gland. CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
  • 46. 3/29/2023 46 (ii) Radioisotopes in Therapy Iodine-131 is used to treat the thyroid for cancers and abnormal conditions such as hyperthyroidism. Phosphorus-32 is used to control the excess of RBC production in bone marrow . Boron-10 is used in the treatment of tumor. Boron-10 gets concentrated in tumor and on irradiation with neutrons, it produces high energy α-particle which kills the cancer. Lead-212 can be attached to monoclonal antibodies for cancer treatment. CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
  • 47. 3/29/2023 47 (iii) In Research: Excellent biological and medicinal study can be carried out with radioactive isotopes as tracers. Generally Carbon-14 are most commonly used. (iv) Sterilization: Thermolabile substances like vitamins, hormones, antibiotics can be safely sterilized by strong radiation sources. e.g. Cobalt-60 may be used for sterilizing surgical instrument. CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
  • 48. 3/29/2023 48 Sr. No. Radio-isotope Applications/Uses 1. Calcium-44, 45 (Ca-44,45) Study of bone structure and bone cancer 2. Carbon-14(C-14) Emit β-radiations, used in medical and pharmaceutical research 3. Strontium-90(Sr-90) Pure β-emitter, used in radiotherapy of superficial carcinoma. 4. Cobalt-60(Co-60) γ-emitter, radiotherapy , sterilization of heat labile substances, study of vitamin B12 5. Cobalt-57(Co-57) Used in diagnosis of pernicious anemia CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
  • 49. 49 Measurement of Radioactivity 3/29/2023 •The measurement of nuclear radiation and detection is an important aspect in the identification of type of radiations (, , ) and to assay the radionuclide emitting the radiation, suitable detectors are required. •The radiations are identified on the basis of their properties. CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
  • 50. 50 CLASSIFICATION 3/29/2023 A)Based on measuring discharge current due to ionization current e.g. Geiger–Müller counter, proportional counter B) Based on visualization of track of ions e.g. bubble chamber, Cloud chamber C) Based on Light emission e.g. Scintillation counter CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D
  • 51. 51 OTHER ….. 3/29/2023 Semiconductor Detector: Solid State Detectors: CHAPTER 21 RADIOPHARMACEUTICALS_PHARM D